1. Home
  2. Labeler Index
  3. Taro Pharmaceuticals U.s.a., Inc.
  4. 51672-1402
  5. NDC Package Code: 51672-1402-8 Calcipotriene And Betamethasone Dipropionate

NDC Package 51672-1402-8 Calcipotriene And Betamethasone Dipropionate

Suspension Topical - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
51672-1402-8
Package Description:
2 BOTTLE in 1 CARTON / 60 g in 1 BOTTLE
Product Code:
51672-1402
Proprietary Name:
Calcipotriene And Betamethasone Dipropionate
Non-Proprietary Name:
Calcipotriene And Betamethasone Dipropionate
Substance Name:
Betamethasone Dipropionate; Calcipotriene
Usage Information:
Calcipotriene and Betamethasone Dipropionate Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp in patients 12 years and older and plaque psoriasis of the scalp and body in patients 18 years and older.Additional pediatric use information is approved for LEO Pharma A/S's Taclonex® (calcipotriene and betamethasone dipropionate) Topical Suspension. However, due to LEO Pharma A/S's marketing exclusivity rights, this drug product is not labeled with that information.
11-Digit NDC Billing Format:
51672140208
NDC to RxNorm Crosswalk:
  • RxCUI: 833461 - calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Suspension
  • RxCUI: 833461 - betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion
  • RxCUI: 833461 - betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Taro Pharmaceuticals U.s.a., Inc.
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Active Ingredient(s):
  • BETAMETHASONE DIPROPIONATE 50 mg/g
  • CALCIPOTRIENE 50 ug/g
    • Pharmacologic Class(es):
  • Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
  • Corticosteroid - [EPC] (Established Pharmacologic Class)
  • Vitamin D Analog - [EPC] (Established Pharmacologic Class)
  • Vitamin D - [CS]
    • Sample Package:
    No
    FDA Application Number:
    ANDA213269
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    09-02-2020
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    51672-1402-41 BOTTLE in 1 CARTON / 60 g in 1 BOTTLE

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 51672-1402-8?

    The NDC Packaged Code 51672-1402-8 is assigned to a package of 2 bottle in 1 carton / 60 g in 1 bottle of Calcipotriene And Betamethasone Dipropionate, a human prescription drug labeled by Taro Pharmaceuticals U.s.a., Inc.. The product's dosage form is suspension and is administered via topical form.

    Is NDC 51672-1402 included in the NDC Directory?

    Yes, Calcipotriene And Betamethasone Dipropionate with product code 51672-1402 is active and included in the NDC Directory. The product was first marketed by Taro Pharmaceuticals U.s.a., Inc. on September 02, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 51672-1402-8?

    The 11-digit format is 51672140208. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-151672-1402-85-4-251672-1402-08